ClariTrial | Search Clinical Trials

Explore/Prostate Cancer

Status

Phase

8,544 results for “Prostate Cancer”

Page 1 of 570

Recruiting

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)

ACE-232 tablets

Acerand Therapeutics (Hong Kong) Limited67 participants8 sites · United StatesCompletes Mar 2028

Compare CT.gov Full analysis →

Completed

Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy

N/AProstate Cancer

Computed Tomography (CT) Scan

M.D. Anderson Cancer Center23 participants1 site · United StatesCompletes Jan 2023

Compare CT.gov Full analysis →

Active

Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer

Phase 3Prostate Cancer

Degarelixapproved GnRH agonistRadiotherapy

European Organisation for Research and Treatment of Cancer - EORTC885 participants39 sites · Belgium, Denmark, FranceCompletes Aug 2023

Compare CT.gov Full analysis →

UNKNOWN

An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer

N/AHigh-Risk and Oligometastatic Prostate Cancer

Apalutamide

Zhujiang Hospital50 participants1 site · ChinaCompletes Aug 2024

Compare CT.gov Full analysis →

Completed

Results posted

Interactive Spaced Education to Optimize Hypertension Management

N/AHypertension

Interactive Spaced Education (ISE) --- online education

VA Office of Research and Development111 participants1 site · United StatesCompletes Mar 2012

Compare CT.gov Full analysis →

Withdrawn

Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery

Phase 1Phase 2Prostate Cancer

ixabepiloneadjuvant therapyintensity-modulated radiation therapy

University of Texas Southwestern Medical Center01 site · United StatesCompletes Oct 2011

Compare CT.gov Full analysis →

Completed

Results posted

PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer

Phase 1Phase 2Prostate Cancer

PROSTVAC-V/FNivolumabProstatectomy+2 more

National Cancer Institute (NCI)24 participants1 site · United StatesCompletes Jun 2023

Compare CT.gov Full analysis →

Terminated

Results posted

Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer

Phase 2Prostate Cancer

DocetaxelEnzalutamidePrednisone

Prostate Cancer Clinical Trials Consortium9 participants5 sites · United StatesCompletes Aug 2017

Compare CT.gov Full analysis →

Completed

Vaccination in Prostate Cancer (VANCE)

Phase 1Prostate Cancer

ChAdOx1.5T4MVA.5T4Cyclophosphamide

University of Oxford40 participants2 sites · United KingdomCompletes May 2018

Compare CT.gov Full analysis →

Terminated

Results posted

GP Extended Action Triptorelin

Phase 4Prostate Cancer

Decapeptyl® SR 22.5mgDecapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mg

Ipsen27 participants35 sites · United KingdomCompletes Feb 2014

Compare CT.gov Full analysis →

Recruiting

Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial

N/ALocalized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8

Biospecimen CollectionComputed TomographyCT-guided Stereotactic Body Radiation Therapy+4 more

Jonsson Comprehensive Cancer Center186 participants1 site · United StatesCompletes Dec 2031

Compare CT.gov Full analysis →

Terminated

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Phase 1Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer

vorinostattemsirolimuslaboratory biomarker analysis+1 more

Roswell Park Cancer Institute13 participants2 sites · United StatesCompletes Aug 2015

Compare CT.gov Full analysis →

Completed

Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

N/AMetastatic CancerProstate Cancer

antiandrogen therapydocetaxelC-11 acetate PET scan+3 more

University of Washington11 participants2 sites · United StatesCompletes May 2010

Compare CT.gov Full analysis →

Recruiting

Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)

Phase 2Prostate Cancer Metastatic

PembrolizumabCarboplatinCabazitaxel

Fundacion Oncosur42 participants1 site · SpainCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

N/ABladder CarcinomaBreast CarcinomaColorectal Carcinoma

Biospecimen CollectionDevice UsageElectronic Health Record Review+3 more

National Cancer Institute (NCI)24,000 participants37 sites · United StatesCompletes Jan 2029

Compare CT.gov Full analysis →

1–15 of 8,544

Explore/Prostate Cancer

Status

Phase

8,544 results for “Prostate Cancer”

Page 1 of 570

Recruiting

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)

ACE-232 tablets

Acerand Therapeutics (Hong Kong) Limited67 participants8 sites · United StatesCompletes Mar 2028

Compare CT.gov Full analysis →

Completed

Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy

N/AProstate Cancer

Computed Tomography (CT) Scan

M.D. Anderson Cancer Center23 participants1 site · United StatesCompletes Jan 2023

Compare CT.gov Full analysis →

Active

Phase 3Prostate Cancer

Degarelixapproved GnRH agonistRadiotherapy

European Organisation for Research and Treatment of Cancer - EORTC885 participants39 sites · Belgium, Denmark, FranceCompletes Aug 2023

Compare CT.gov Full analysis →

UNKNOWN

An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer

N/AHigh-Risk and Oligometastatic Prostate Cancer

Apalutamide

Zhujiang Hospital50 participants1 site · ChinaCompletes Aug 2024

Compare CT.gov Full analysis →

Completed

Results posted

Interactive Spaced Education to Optimize Hypertension Management

N/AHypertension

Interactive Spaced Education (ISE) --- online education

VA Office of Research and Development111 participants1 site · United StatesCompletes Mar 2012

Compare CT.gov Full analysis →

Withdrawn

Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery

Phase 1Phase 2Prostate Cancer

ixabepiloneadjuvant therapyintensity-modulated radiation therapy

University of Texas Southwestern Medical Center01 site · United StatesCompletes Oct 2011

Compare CT.gov Full analysis →

Completed

Results posted

PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer

Phase 1Phase 2Prostate Cancer

PROSTVAC-V/FNivolumabProstatectomy+2 more

National Cancer Institute (NCI)24 participants1 site · United StatesCompletes Jun 2023

Compare CT.gov Full analysis →

Terminated

Results posted

Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer

Phase 2Prostate Cancer

DocetaxelEnzalutamidePrednisone

Prostate Cancer Clinical Trials Consortium9 participants5 sites · United StatesCompletes Aug 2017

Compare CT.gov Full analysis →

Completed

Vaccination in Prostate Cancer (VANCE)

Phase 1Prostate Cancer

ChAdOx1.5T4MVA.5T4Cyclophosphamide

University of Oxford40 participants2 sites · United KingdomCompletes May 2018

Compare CT.gov Full analysis →

Terminated

Results posted

GP Extended Action Triptorelin

Phase 4Prostate Cancer

Decapeptyl® SR 22.5mgDecapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mg

Ipsen27 participants35 sites · United KingdomCompletes Feb 2014

Compare CT.gov Full analysis →

Recruiting

Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial

N/ALocalized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8

Biospecimen CollectionComputed TomographyCT-guided Stereotactic Body Radiation Therapy+4 more

Jonsson Comprehensive Cancer Center186 participants1 site · United StatesCompletes Dec 2031

Compare CT.gov Full analysis →

Terminated

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Phase 1Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer

vorinostattemsirolimuslaboratory biomarker analysis+1 more

Roswell Park Cancer Institute13 participants2 sites · United StatesCompletes Aug 2015

Compare CT.gov Full analysis →

Completed

Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

N/AMetastatic CancerProstate Cancer

antiandrogen therapydocetaxelC-11 acetate PET scan+3 more

University of Washington11 participants2 sites · United StatesCompletes May 2010

Compare CT.gov Full analysis →

Recruiting

Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)

Phase 2Prostate Cancer Metastatic

PembrolizumabCarboplatinCabazitaxel

Fundacion Oncosur42 participants1 site · SpainCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

N/ABladder CarcinomaBreast CarcinomaColorectal Carcinoma

Biospecimen CollectionDevice UsageElectronic Health Record Review+3 more

National Cancer Institute (NCI)24,000 participants37 sites · United StatesCompletes Jan 2029

Compare CT.gov Full analysis →

1–15 of 8,544